BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28643014)

  • 21. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
    Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and surgical therapy of uterine sarcoma.
    Vrzic-Petronijevic S; Likic-Ladjevic I; Petronijevic M; Argirovic R; Ladjevic N
    Acta Chir Iugosl; 2006; 53(3):67-72. PubMed ID: 17338203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.
    Abeler VM; Røyne O; Thoresen S; Danielsen HE; Nesland JM; Kristensen GB
    Histopathology; 2009 Feb; 54(3):355-64. PubMed ID: 19236512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?
    Feng W; Malpica A; Skaland I; Gudlaugsson E; Robboy SJ; Dalen I; Hua K; Zhou X; Baak JP
    PLoS One; 2013; 8(10):e75899. PubMed ID: 24146786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival outcomes and prognostic factors of endometrial stromal sarcoma and undifferentiated uterine sarcoma.
    Cabrera S; Bebia V; Acosta U; Franco-Camps S; Mañalich L; García-Jiménez A; Gil-Moreno A
    Clin Transl Oncol; 2021 Jun; 23(6):1210-1219. PubMed ID: 33210235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of 80 cases with uterine carcinosarcoma, leiomyosarcoma and endometrial stromal sarcoma in China, 1988-2007.
    Gao Y; Meng H; Zhang Y; Jiao T; Hui N
    Int J Clin Exp Pathol; 2014; 7(4):1616-24. PubMed ID: 24817958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of lymphadenectomy in uterine leiomyosarcomas and endometrial stromal sarcomas: Systematic review and meta-analysis.
    Li Y; Gong Q; Peng J; Liu Y; Jiang Y; Zhang S
    Eur J Obstet Gynecol Reprod Biol; 2022 Dec; 279():94-101. PubMed ID: 36308940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    Wien Klin Wochenschr; 2004 Feb; 116(4):135-9. PubMed ID: 15038405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study.
    Raspagliesi F; Maltese G; Bogani G; Fucà G; Lepori S; De Iaco P; Perrone M; Scambia G; Cormio G; Bogliolo S; Bergamini A; Bifulco G; Casali PG; Lorusso D
    Gynecol Oncol; 2017 Jan; 144(1):90-95. PubMed ID: 27817933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
    Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
    Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine sarcomas in South African black women: a clinicopathologic study with ethnic considerations.
    Amant F; Dreyer L; Makin J; Vergote I; Lindeque BG
    Eur J Gynaecol Oncol; 2001; 22(3):194-200. PubMed ID: 11501770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of the diagnostic criteria distinguishing endometrial stromal sarcoma, low grade from undifferentiated endometrial sarcoma, 2 entities within the invasive endometrial stromal neoplasia family.
    Feng W; Malpica A; Robboy SJ; Gudlaugsson E; Hua K; Zhou X; Baak JP
    Int J Gynecol Pathol; 2013 May; 32(3):299-306. PubMed ID: 23545579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical management of uterine sarcomas.
    Amant F; Coosemans A; Debiec-Rychter M; Timmerman D; Vergote I
    Lancet Oncol; 2009 Dec; 10(12):1188-98. PubMed ID: 19959075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma.
    Arita S; Kikkawa F; Kajiyama H; Shibata K; Kawai M; Mizuno K; Nagasaka T; Ino K; Nomura S
    Int J Gynecol Cancer; 2005; 15(2):329-36. PubMed ID: 15823121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic indicators in WHO 2003 low-grade endometrial stromal sarcoma.
    Feng W; Hua K; Gudlaugsson E; Yu Y; Zhou X; Baak JP
    Histopathology; 2013 Apr; 62(5):675-87. PubMed ID: 23425310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
    Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
    Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-grade endometrial stromal sarcoma and undifferentiated endometrial sarcoma: a comparative analysis emphasizing the importance of distinguishing between these two groups.
    Bartosch C; Exposito MI; Lopes JM
    Int J Surg Pathol; 2010 Aug; 18(4):286-91. PubMed ID: 19482859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.